Respiratory Insufficiency Sleep Apnoe Hypopnoe Syndrome SAHS Attila
- Slides: 33
Respiratory Insufficiency Sleep Apnoe Hypopnoe Syndrome (SAHS) Attila Somfay SZTE Tüdőgyógyászati Tanszék, Deszk
Classification of respiratory insufficiency 1. Progression in time – acute (p. H!) - chronic 2. Pathophysiology - type I (hypoxemia=Pa. O 2<60 Hgmm) - type II (hypoxemia + hypercapnia=Pa. CO 2>50 Hgmm) 3. Pathomechanism - V/Q mismatch - hypoventilation - limited diffusion - right-left shunt 4. Etiology - airway - lung parenchyma - lung vasculature - chest wall and pleura - neuromuscular
Alveolar gas equation: PA (mm. Hg) = (PB-47) x FIO 2 – 1. 2 x Pa. CO 2 102 = 150 - 48
VCO 2 PCO 2= VA
The causes of hypoventilation Site of abnormality Central Brain stem Spinal cord Peripheral nerves Neuromusc. Junction Upper airway Chest wall Respiratory muscles Disease Primary hypoventilation sy, barbiturat, opiat Encephalitis, haemorrh. , trauma Cervical trauma, poliomyelitis Guillain-Barré-sy, bilat. n. phrenicus paresis Myasthenia gravis Trachea stenosis Kyphoscoliosis, trauma Muscular dystrophies
Diminished diffusion • • • Transit (contact) time: 0. 75 s Equilibration: 0. 25 s Exercise + diminished diffusion: Pa. O 2<60 Hgmm Pa. CO 2 : no change or decreases Causes: alveolitis fibrotisans, sarcoidosis, pneumoconiosis, connective tissue diseases, drugs, irradiation, alveolar cell cc, Goodpasture-sy, CHF
Right-left shunt • Anatomic: lung (a-v malformation), heart (ASD, VSD, Eisenmenger-sy) • Functional: V/Q=0; ARDS, atelectasia, oedema, haemorrhagia • Hypercapnia: no or rarely • Hypoxemia: cannot be corrected by 100% O 2
Ventilation-perfusion mismatch • “Functional shunt”, most frequent cause of hypoxemia • COPD, ILD, pulmonary embolism • Regional differences in airway resistance and lung compliance • Hypercapnia: only in severe cases (blue bloater) • Hypoxemia: correctable with small incraese in FIO 2
Symptoms of hypoxemia és hypercapnia HYPOXEMIA Cyanosis Tachycardia Hypertension Headache Agitation Dezorientation Loss of consciousness Fibrillation, bradycardia Convulsions, retina bleeding Brain damage HYPERCAPNIA Warm, wet skin Tachycardia Hypertension Headache myosis, papilla oedema Agitation Dezorientation, sleepiness Tremor Pathologic reflexes Loss of consciousness Coma
Diseases leading to resp. insuff. Airway Lung parenchyma Hyperpermeability (ARDS) Pulmonary vascular Heart failure with cyanosis Neuromuscular Trauma (head, neck) Ptx, pleurisy Chest wall(deform. , trauma) Drug overdose (sedatives) Type I + + + + Type II + + +
Oxigen supplementation in chronic resp. insuff. NOTT: Ann Intern Med, 1980 BMC: Lancet, 1981 only way to prolong survival in case of chronic resp. insuff. Indication: (stable condition) • Pa. O 2 < 55 mm. Hg or SAT < 88% • 55 mm. Hg < Pa. O 2 < 60 mm. Hg with pulmonary hypertension, polyglobulia or right heart failure Aim: Pa. O 2 ≈ 60 mm. Hg vagy SAT ≈ 90 % CAVE: CO 2 retention in COPD (max. 1 -2 L/min)! Dosage: > 15 h/day
Pa. O 2 < 55 Hgmm Pa. O 2 > 55 Hgmm
ARDS
The causes of ARDS Shock Infection Hematologic Inhalation Ingestion Embolism Metabolic Other Trauma, haemorrhagia, acut hypovolemia (severe burning of the skin) Pulmonary (pneumonia!) - extrapulm. sepsis DIC, abundant transfusion NO 2, NH 4, Cl, SO 2, gases, O 2 -tox. (FIO 2 >0. 5), gastric acid aspiration Paraquat, barbiturat, aspirin, narcotics, lidocain, hydrochlorotiazid fat, air, cell aggregate Diabetic ketoacidosis, uremia Pancreatitis, high altitude, irradiation, aspiration, drawn in water, re-exspansion
Diagnosis of ARDS • Acute onset (1 -3 days) • One or more risk factors • Chest X-ray: new, bilateral, snow flake – like infiltrates • Exclusion: heart failure, fluid overdose, chronic lung disease • Hypoxemia not corrected with O 2: - mild: Pa. O 2/FIO 2 200 -300 mm. Hg - moderate: 100 -200 mm. Hg - severe: < 100 mm. Hg
Non-invasive ventilation (NIV) in global respiratory insufficiency - Bi. PAP
Sleep apnoe-hypopnoe syndrome (SAHS) • Dg: apnoe >5/h , >30/sleep period, SAT decrease: minimum 4% • Apnoe: > 10 s • Arousal (EEG) defraction of sleep • Apnoe index: Number of apnoe/h: <5 - mild: 5 -15 - moderate: 15 -30 - severe: >30
Types of SAHS • Central (kb. 5%) • Obstructive (site: pharyngeal level) • Mixed Risk factors: - obesity - alcohol - sedatives
Symptoms of SAS • • • Daytime sleepiness Morning headache, tenebrosity Change in personality Strong hoarsness Movements during sleep Enuresis nocturna Impotency Hypertonia, arrhythmias Right heart failure
Score: 0 – 24 Upper limit of normal: 9 Normal : 5. 9 ± 2. 2 SAS: 16 ± 4. 4
Diagnosis of SAS (poliszomnográfia) • • • EEG EOG EMG EKG ABG, pulzoximetry Detection of airflow Detection of breathing movements, leg movements Voice recording Video
Therapy of SAS • Change in life style • n. CPAP, Bi. PAP • • • Medroxiprogesteron (Provera) Surgery Acetazolamid (Diamox, Fonurit) Almitrin Protryptilin
c. PAP with nasal mask
Effect of c. PAP on Sp. O 2
- Hypopnoe
- Conducting zone respiratory
- Sahs severo
- Aspire sahs
- Sahs hac
- Pseudo convergence insufficiency
- Muscle movement
- Percussion test for venous insufficiency
- Active insufficiency
- Esodeviation
- Eye lesions
- Epi stool
- Convergence insufficiency latham
- Come sleep o sleep summary
- Module 16 sleep patterns and sleep theories
- Adults spend about ______% of their sleep in rem sleep.
- Module 23 sleep patterns and sleep theories
- Module 23 sleep patterns and sleep theories
- Tompos attila
- Villámvédelmi besorolás táblázat
- Nke hhk
- Dobi attila
- Attila technologies
- Agsonomi
- Attila the hun leadership style
- Melegh attila
- Kromoszféra
- Somfay attila
- Attila ilhan poems
- Sanglier de turquie
- Piros attila bme
- Dr somfay attila
- Derzsényi attila
- Somfay attila